Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading and Operational Update

26 Jan 2023 10:32

RNS Number : 9746N
CAP-XX Limited
26 January 2023
Β 

Dissemination of a Regulatory Announcement that contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

Β 

Β 

26 January 2023

Β 

Β 

CAP-XX Limited

("CAP-XX" or the "Company")

Β 

Trading and Operational Update

Β 

Β 

CAP-XX Limited, a world leader in the design and manufacture of supercapacitors and energy management systems, provides the following trading and operational update in relation to the current financial year:

Β 

Β· Total revenue for the half year to 31 December 2022 down 34% to A$1.6m on corresponding prior half-year (H1 2021: A$2.4m).

Β 

Β· Product sales down 40% on corresponding half-year. The Company does not believe it has not lost any significant business to competitors.

Β 

Β· Sales order book at 31 December 2022 was 47% higher than at beginning of July 2022 and 85% higher than at August 2022.

Β 

Β· Sales order book has increased 41% since 31 December 2022. Sales pipeline continues to increase - now in excess ofΒ US$65 millionΒ p.a.

Β 

Β· Performance of Seven Hills production continues to improve with reject rates reducing by nine percentage points compared to the previous period.

Β 

Β· Adjusted EBITDA* for the half year expected to be a loss ofΒ A$966k (H1 2021: Adjusted EBITDA lossΒ A$305k).

Β 

Β· Cash reserves as at 31 December 2022 wereΒ A$0.5 million with no debt. In addition, the Company has an unused line of credit of approximately A$1.7 million ensuring current funding is sufficient for the Company's expected needs.

Β 

Β· The interim results will be released on 28 February 2023.

* Adjusted to exclude legal expenses for patent infringement and the amortisation of share-based payment expenses.

Β 

Β 

As foreshadowed at the time of the full year results statement and in the subsequent AGM statement, the current financial year started slower than the prior half-year due to a combination of market influences. Whilst the Board had been hopeful that the impact of these market influences would reduce, this has not occurred with a consequential impact on CAP-XX's revenues. These market influences include: industry wide supply chain bottlenecks, especially inΒ China, a global shortage of integrated circuits, which is affecting our customer order volumes, and increasing pessimism over the state of the global economy. The flow-on effects of factory closures in Asia led to delays in shipments of critical components and has, in turn, resulted in delayed sales of supercapacitors. Further, concerns about the ongoing war in Ukraine, rising interest rates and energy costs, and the threat of recession have also caused some customers to reduce their purchase orders as they look to reduce their inventory levels and to delay new product launches. For CAP-XX, the greatest falls have been in the demand from the Asian/APAC region for cylindrical supercapacitors.

Our market intelligence suggests that the drop in our H1 sales is in line with the experience of our direct competitors' and other component suppliers in the same and related markets. To our knowledge, no significant business has been lost to a competitor during this period.

Following a review of the sales for the first half of the financial year and the outlook for the second half, the Board is now of the view that the revenue for the full financial year ending 30 June 2023 will be significantly below current market forecasts, and that as a result, the Company will be loss making at the adjusted EBITDA level.

Conversely, the CAP-XX sales pipeline continues to grow strongly and is currently over US$65 million. The timing of when these opportunities will translate into meaningful sales is dependent on many factors outside of our control. On average, we are finding that sales conversion for small projects or projects for smaller companies typically takes between 12 to 18 months, while larger volume projects or larger customers are typically 24 to 36 months. In the case of automotive and medical projects, these times can stretch to over five years. Factors which drive these timescales include: the customer's anticipated outlook for end-market demand and their availability of resources, external approvals and end-customer related engineering variations. The Board is confident that the second half performance will be significantly better than the first half based on: CAP-XX's order intake over Christmas and New Year steadily increasing in what is a historically slow period for orders; some customers beginning to bring delivery dates forward; and new projects moving into production in the second half of the year. In addition, there are signs of a recovery in the cylindrical supercapacitor supply chain and improving orders for cylindrical supercapacitors.

Β 

Anthony Kongats, CEO of CAP-XX said:

"The first half of the year has been very challenging, but the Board is confident that CAP-XX will see a rebound in the second half, based on recent customer orders received and design wins. Our operational performance continues to improve and we look forward to a much stronger sales performance as projects won move into the production phase in the second half of the year against the background of a continuing tough market."

For further information contact:

Β 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

Β 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

Β 

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance) +44Β (0) 20 3328 5656

Tony Quirke (Sales and Corporate Broking)

Β 

Cenkos Securities plc (Joint Broker)

Neil McDonald / Pete Lynch +44 (0) 13 1220 6939

Β 

Β 

Β 

More information is available atΒ www.cap-xx.com

Β 

Notes to Editors:

Β 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package.Β These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visitΒ www.cap-xx.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFVILLIRFIV
Date   Source Headline
2nd Feb 20267:00 amRNSInterim Results
23rd Jan 20267:00 amRNSNotice of Interim Results & Investor Presentation
19th Dec 202510:13 amRNSReceipt of R&D tax credit
19th Dec 202510:13 amRNSReceipt of R&D tax credit
10th Dec 20252:16 pmRNSHolding(s) in Company
28th Nov 20255:00 pmRNSTotal Voting Rights
28th Nov 202510:13 amRNSResult of AGM
14th Nov 20257:00 amRNSIssue of Shares and Director/PDMR Shareholding
10th Nov 20257:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSFinal results and notice of AGM
30th Oct 20251:02 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSImplementation of Warehouse Management System
10th Sep 202511:48 amRNSHolding(s) in Company
7th Aug 20257:00 amRNSHolding(s) in Company
5th Aug 20257:00 amRNS-RDesign Win with Global Semiconductor Manufacturer
31st Jul 20255:00 pmRNSTotal Voting Rights
25th Jul 20257:00 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSUpdate re. collaboration with SCHURTER
2nd Jul 20257:00 amRNSHolding(s) in Company
1st Jul 20257:29 amRNSIssue of Shares and Director/PDMR Shareholdings
30th Jun 20257:00 amRNSGlobal Distribution Agreement with RS Group plc
9th Jun 20257:00 amRNSBusiness Update and Appointment of Interim CFO
30th May 202510:32 amRNS-RUpdated website
13th May 202511:31 amRNS-RDesign Win with Multinational Conglomerate
30th Apr 20251:57 pmRNSChange of Auditor
26th Mar 20257:00 amRNSGrant of share options
19th Mar 20257:00 amRNSChange of Board Structure and Grant of Options
18th Mar 20259:35 amRNSGlobal Distribution Agreement with Premier Farnell
12th Mar 20252:43 pmRNSTechnology Cooperation Agreement with SCHURTER
7th Mar 20257:00 amRNSMaster Distribution Agreement with Waldom
17th Feb 20257:00 amRNSHalf-year Results
11th Feb 20257:00 amRNSNotice of Interim Results & Investor Presentation
31st Jan 20255:00 pmRNSTotal Voting Rights
21st Jan 20254:27 pmRNSIssue of Shares and Director/PDMR Shareholding
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
17th Jan 20257:00 amRNS-RDistribution agreement with JM Elektronik
15th Jan 20257:00 amRNSFirst shipment to SCHURTER AG
13th Jan 202511:29 amRNSResult of AGM
7th Jan 20257:00 amRNSManagement and board changes
31st Dec 20241:00 pmRNSTotal Voting Rights
9th Dec 202410:19 amRNSNotice of AGM
5th Dec 20248:18 amRNSResult of General Meeting
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20249:57 amRNSDirectors' Subscription
29th Nov 20247:00 amRNSAudited results for the year ended 30 June 2024
5th Nov 20247:00 amRNSResult of Retail Offer, Notice of GM and TVR
1st Nov 20247:00 amRNSResult of Placing
31st Oct 20244:40 pmRNSRetailBook Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.